Hainan Medical Tourism Zone to Establish Intellectual Property Exchange – Business & Economy


HAIKOU / China /, November 18. / TASS /. The Lecheng International Medical Tourism Zone, east of Hainan Island, plans to create an intellectual property exchange for cross-border medical equipment licensing transactions, reports the Hainan Daily.

According to the newspaper, as part of the task set earlier this week, Lecheng’s management signed a strategic cooperation agreement with the Hainan International Intellectual Property Exchange Center as part of a task set out earlier this week. week. Once the new platform is in place, transactions with licenses granting the right to use medical technology will be done primarily online.

“Through this close cooperation, equipment manufacturing companies will be able to transfer the rights to inventions,” said Liu Xiaolei, deputy director of management of Lecheng Advanced Development Zone. “The result will be a cluster of medical technology exchange, interacting with Chinese and foreign markets.”

She stressed that Lecheng is expected to become a “top-notch innovation platform of international level” in the relevant field.

As Sheng Yang, chairman of the board of the Hainan International Intellectual Property Clearinghouse, said, his organization will actively promote transaction security and the optimization of foreign exchange settlements. “We can also provide businesses with financial services, including investments needed for development,” he added.

In February 2013, the Chinese State Council approved an initiative to establish an advanced health cluster in eastern Hainan. Lecheng is a short drive from the annual Boao Forum for Asia and is considered the island’s “medical landmark”. In 2019, this special zone received about 75,000 tourists, and the total income from the main activities of hospitals, sanatoriums and other institutions located in its territory exceeded 640 million yuan (about $ 96 million at the current exchange rate), after increasing by 75% year on year.


Comments are closed.